John Quisel

John Quisel currently serves as the Chief Executive Officer, having previously held the position of Chief Business Officer at Acceleron Pharma. His career includes significant legal experience, working at prominent law firms such as Ropes & Gray and Foley Hoag. Quisel’s academic credentials are impressive; he received his undergraduate degree from Harvard College, graduating summa cum laude, and went on to earn a Master of Science from Stanford University. He completed a PhD in Biological Sciences from MIT and holds a Juris Doctor from Harvard Law School. Notably, he led the in-licensing of sotatercept for pulmonary hypertension from Bristol-Myers Squibb and played a key role in negotiating the collaboration agreement for the development and commercialization of luspatercept.